FDA Approves First Once-a-day Three Drug Combination Tablet

The key to successful HIV drug treatment is adhering to the prescribed combination each and everyday. To that end, drug manufacturers Gilead Sciences and Bristol-Myer-Squibb have gained FDA approval for their joint venture; the first once-a-day three drug combination tablet for the treatment of HIV. Atripla is the name of the new tablet that combines the existing HIV drugs Sustiva (efavirenz), Emtriva (emtricitabine) and Viread (tenofovir disoproxil fumarate). Read more about this exciting breakthrough.

Related items...

HIV Medication Fact Sheets

New Drug Shows Promise

HIV Drug Facts